N/A
Manufactured by Waylis Therapeutics LLC
27,867 FDA adverse event reports analyzed
Last updated: 2026-04-14
OMEGA 3 ACID ETHYL ESTERS is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Waylis Therapeutics LLC. The most commonly reported adverse reactions for OMEGA 3 ACID ETHYL ESTERS include FLUSHING, NAUSEA, FATIGUE, DRUG INEFFECTIVE, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for OMEGA 3 ACID ETHYL ESTERS.
Out of 15,230 classified reports for OMEGA 3 ACID ETHYL ESTERS:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 27,867 FDA FAERS reports that mention OMEGA 3 ACID ETHYL ESTERS. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FLUSHING, NAUSEA, FATIGUE, DRUG INEFFECTIVE, DIARRHOEA, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Waylis Therapeutics LLC in connection with OMEGA 3 ACID ETHYL ESTERS. Always verify the specific product and NDC with your pharmacist.